Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Lilly's Foundayo wins U. K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U. S. market.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC